E-mail Comment Del.icio.us Digg Reddit Technorati Furl

Illumina Launches Custom Methylation Application

Apr 16, 2007 methylation

Today Illumina, Inc. (NASDAQ:ILMN) launched a custom-content methylation product that allows researchers to perform methylation profiling specific to individual CpG sites. From the press release:

Joining Illumina’s GoldenGate Methylation Cancer Panel I, the Company’s first standard methylation product launched in January 2007, investigators now have the option to select their favorite genes or gene regions to cost-effectively survey up to 1,536 methylation sites of choice across 96 samples simultaneously.

“Custom methylation adds another degree of integration to analysis with genetic and epigenetic data. Researchers who are interested in expediting the speed and scope of their methylation studies in areas such as cancer, developmental disorders, stem cell, aging, and neurological diseases now have the ability to select specific CpG sites from chosen genes” said Marina Bibikova, Ph.D., Staff Scientist at Illumina.

Link

No related posts.

Related posts brought to you by Yet Another Related Posts Plugin.

This entry was posted on Monday, April 16th, 2007 at 2:47 pm and is filed under methylation. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.